// App-Quantinova.ai

P1693 : THROMBOMODULIN RESISTANCE: A NEW PROTHROMBOTIC PATHWAY IN COVID-19

Researchers

Presenter

  • Adrin Montao

Principal Investigators

  • Ana Marco

  • Francisco Jos Lpez Jaime

  • Ihosvany Fernndez Bello

  • Ignacio Mrquez Gomez

  • Jose Mara Reguera Iglesias

  • Pascual Marco

Medical Centers

  • Hospital General Universitario Dr. Balmis ,Alicante,Spagna

  • Unidad de Hemostasia y Trombosis,Hospital Universitario Regional de Málaga, IBIMA,Málaga,Spain

  • Hospital General Universitario Dr. Balmis ,Alicante,Spagna

  • Servicio de Enfermedades Infecciosas,Hospital Universitario Regional de Málaga,Málaga,Spagna

  • Unidad de Hemostasia y Trombosis,Hospital Universitario Regional de Málaga, IBIMA,Málaga,Spain

  • Hospital General Universitario Dr. Balmis ,Alicante,Spagna

  • Unidad de Hemostasia y Trombosis,Hospital Universitario Regional de Málaga, IBIMA,Málaga,Spain

  • Unidad de Hemostasia y Trombosis,Hospital Universitario Regional de Málaga, IBIMA,Málaga,Spain

  • Servicio de Enfermedades Infecciosas,Hospital Universitario Regional de Málaga,Málaga,Spagna

  • Servicio de Enfermedades Infecciosas,Hospital Universitario Regional de Málaga,Málaga,Spagna

  • Hospital General Universitario Dr. Balmis ,Alicante,Spagna

  • Hospital General Universitario Dr. Balmis ,Alicante,Spagna

  • Servicio de Enfermedades Infecciosas,Hospital Universitario Regional de Málaga,Málaga,Spagna

  • Hospital General Universitario Dr. Balmis ,Alicante,Spagna

  • Servicio de Enfermedades In

  • Hospital General Universitario Dr. Balmis ,Alicante,Spagna

  • Hospital General Universitario Dr. Balmis ,Alicante,Spagna

  • Hospital General Universitario Dr. Balmis ,Alicante,Spagna

  • Unidad de Hemos

  • Hospital General Universitario Dr. Balmis ,Alicante,Spagna

Locations

  • Spain

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Infectious Diseases (ID)

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Thrombomodulin alfa

  • Hemostatic Solution

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved